Insight Molecular Diagnostics Inc (IMDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 13,783 | 17,368 | 11,803 | 19,993 | 32,053 |
| Marketable Securities | 441 | 530 | 553 | 433 | 419 |
| Receivables | 1,882 | 1,716 | 1,901 | 2,012 | 1,990 |
| Other current assets | 139 | 191 | 421 | 2,121 | 0 |
| TOTAL | $16,917 | $20,984 | $15,648 | $25,536 | $36,636 |
| Non-Current Assets | |||||
| PPE Net | 4,076 | 5,997 | 6,403 | 8,672 | 9,256 |
| Intangibles | 56,617 | 56,639 | 56,661 | 61,633 | 107,049 |
| Other Non-Current Assets | 3,977 | 3,920 | 4,088 | 4,250 | 4,403 |
| TOTAL | $64,670 | $66,556 | $67,152 | $74,555 | $120,708 |
| Total Assets | $81,587 | $87,540 | $82,800 | $100,091 | $157,344 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,136 | 875 | 1,395 | 1,253 | 1,826 |
| Accrued Expenses | 6,087 | 5,920 | 7,024 | 8,033 | 10,299 |
| TOTAL | $8,033 | $7,667 | $9,430 | $12,106 | $12,952 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 35,992 | 36,273 | 35,437 | 53,693 | 67,535 |
| TOTAL | $35,992 | $36,273 | $35,437 | $53,693 | $67,535 |
| Total Liabilities | $44,025 | $43,940 | $44,867 | $65,799 | $80,487 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 8,261 | 8,241 | 8,241 | 5,964 | 5,932 |
| Common Shares | 309,995 | 309,535 | 295,533 | 294,929 | 292,536 |
| Retained earnings | -272,465 | -265,976 | -257,643 | -260,676 | -215,698 |
| Other shareholders' equity | 32 | 41 | 43 | 39 | 19 |
| TOTAL | $37,562 | $43,600 | $37,933 | $34,292 | $76,857 |
| Total Liabilities And Equity | $81,587 | $87,540 | $82,800 | $100,091 | $157,344 |